The aim of this study was to investigate the relationship among motility disorders, dyspeptic symptoms, and plasma levels of gastrointestinal hormones in cancer patients who were well controlled for post-chemotherapy emesis.
Laboratory of Experimental Pathophysiology S. de Bellis, National Institute for Digestive Diseases, Via F. Valente, 4, 70013 Castellana, Grotte (BA), Italy.